Use of Depo-Provera was significantly associated with the development of cervical infections in a study of 819 women, said Charles S. Morrison, Ph.D.
Even after adjustment for sexual behavior and demographic traits including condom use and multiple sex partners, women who used Depo-Provera (medroxyprogesterone) were more likely to developed gonorrhea or chlamydia within a year, compared both with women who used oral contraceptives and controls, said Dr. Morrison of Family Health International, a research organization in Research Triangle Park, N.C.
The use of oral contraceptives was not associated with increased risk or development of infections.
After a mean follow-up of 337 days, 45 women in the prospective cohort study had developed at least one cervical infection.
Most of the women were single (77%) and nulliparous (75%). They ranged in age from 15 to 45 years, with a median age of 22 years (Sex. Transm. Dis. 31[9]:561-67, 2004).
The researchers calculated risk based on how many women became infected within a year (woman-years) and found a rate of 13.7 infections/100 woman-years in the Depo-Provera group, significantly higher than women in the oral contraceptive group (3.9 infections/100 woman-years) and the control group (6/100 woman-years).
More research is needed to determine whether Depo-Provera itself creates a susceptibility to infection.
Meanwhile, women taking Depo-Provera can reduce their risk of infection by using additional protection if they are in nonmonogamous relationships.
"All of the labeling and educational material for Depo-Provera includes information about how it doesn't protect women from sexually transmitted diseases," according to Rebecca Hamm, who is a spokesperson for Pfizer, which markets Depo-Provera.
The study seems to reinforce the need for women using hormonal contraception to receive not only those materials, but also additional reminders from their physicians about the need to protect themselves if they are at increased risk for STDs, she commented in an interview with this newspaper.
BY HEIDI SPLETE
Senior Writer
COPYRIGHT 2004 International Medical News Group
COPYRIGHT 2004 Gale Group